IP Library Granted Patent US 7,442,501
Granted Patent B2
US 7,442,501 · App. 10/347,470 · Granted Oct 28, 2008

SQV nucleic acids and polypeptides

Assignee: Massachusetts Institute of Technology
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,442,501
App. No.
10/347,470
Granted
Oct 28, 2008
Kind
B2
Abstract

The invention generally features sqv nucleic acid and polypeptide molecules associated with connective tissue diseases, progeroid disorders, and aging, and methods for isolating such molecules.

Claims (18)

1. A method of identifying a compound that modulates a glycosaminoglycan biosynthetic biological activity, said method comprising the steps of:

(a) providing a first cell comprising a wild-type sqv nucleic acid molecule;

(b) providing a second cell comprising a sqv-1, sqv-2, sqv-4, sqv-5, or sqv-6 mutant nucleic acid molecule;

(c) contacting said first cell with a candidate compound;

(d) contacting said second cell with said candidate compound; and

(e) detecting, in a protein extract from said first or second cell, an alteration of an enzymatic activity that contributes to the production of a glycosaminoglycan in said first cell when compared to said second cell, wherein said alteration identifies said compound as modulating a glycosaminoglycan biosynthetic biological activity.

2. The method of claim 1 , wherein said first and said second cells are mammalian cells.

3. The method of claim 1 , wherein said first and said second cells are nematode cells.

4. A method of identifying a compound that modulates a glycosaminoglycan biosynthetic biological activity, said method comprising the steps of:

(a) providing a first nematode comprising a wild-type sqv nucleic acid molecule;

(b) providing a second nematode comprising a sqv-1, sqv-2, sqv-4, sqv-5, or sqv-6 mutant nucleic acid molecule;

(c) contacting said first nematode with a candidate compound;

(d) contacting said second nematode with said candidate compound; and

(e) detecting, in a protein extract from said first or second nematode, an alteration of an enzymatic activity that contributes to the production of a glycosaminoglycan in said first nematode when compared to said second nematode, wherein said alteration identifies said compound as modulating a glycosaminoglycan biosynthetic biological activity.

5. The method of claim 1 , wherein said detecting is an immunological assay.

6. The method of claim 1 , wherein said sqv mutant nucleic acid molecule is sqv-5.

7. The method of claim 4 , wherein said detecting is an immunological assay.

8. The method of claim 4 , wherein said sqv mutant nucleic acid molecule is sqv-5.

Assignments (3)
CONFIRMATORY LICENSE Recorded Mar 5, 2012
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027802/0640 →
CONFIRMATORY LICENSE Recorded Aug 27, 2008
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021447/0420 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2003
From: HORVITZ, H. ROBERT; HWANG, HO YON
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 014423/0134 →
Continuity (3)
Provisional Application 6039093000 · Jun 24, 2002
Provisional Application 6034963000 · Jan 18, 2002
Related Publication 20040002054A1 · Jan 1, 2004